Azilsartan Reduced TNF-α and IL-1β Levels, Increased IL-10 Levels and Upregulated VEGF, FGF, KGF, and TGF-α in an Oral Mucositis Model

被引:12
作者
de Araujo, Aurigena Antunes [1 ,2 ]
Varela, Hugo [3 ]
Carvalho Xavier de Medeiros, Caroline Addison [4 ,5 ]
de Castro Brito, Gerly Anne [6 ]
de Lima, Kenio Costa [7 ]
de Moura, Ligia Moreno [3 ,8 ]
de Araujo Junior, Raimundo Fernandes [9 ]
机构
[1] Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil
[2] Fed Univ Rio Grande Norte UFRN, Dept Biophys & Pharmacol, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil
[3] Univ Fed Rio Grande do Norte, Postgrad Program Publ Hlth, Natal, RN, Brazil
[4] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil
[5] State Univ Rio Grande Norte UERN, Postgrad Program Hlth & Soc, Natal, RN, Brazil
[6] Univ Fed Ceara, Postgrad Program Pharmacol & Morphol, Dept Morphol, Fortaleza, CE, Brazil
[7] Univ Fed Rio Grande do Norte, Dept Dent, Postgrad Program Publ Hlth & Hlth Sci, Natal, RN, Brazil
[8] Univ Potiguar UnP, Natal, RN, Brazil
[9] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol & Hlth Sci, Natal, RN, Brazil
来源
PLOS ONE | 2015年 / 10卷 / 02期
关键词
GROWTH-FACTORS; WOUND MACROPHAGES; CELL-MIGRATION; PREVENTION; CYTOKINES; THERAPY; RADIOCHEMOTHERAPY; CHEMOTHERAPY; PATHOGENESIS; TELMISARTAN;
D O I
10.1371/journal.pone.0116799
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oral mucositis (OM) is a common complication of treatments for head and neck cancer, particularly radiotherapy with or without chemotherapy. OM is characterised by oral erythema, ulceration, and pain. The aim of this study was to evaluate the effect of azilsartan (AZT), an angiotensin II receptor antagonist, on 5-fluorouracil (5-FU)-induced oral mucositis (OM) in Syrian hamsters. OM was induced by the intraperitoneal administration of 5-FU on experimental days 1 (60mg/Kg) and 2 (40mg/Kg). Animals were pretreated with oral AZT (1, 5, or 10 mg/kg) or vehicle 30 min before 5-FU injection and daily until day 10. Experimental treatment protocols were approved by the Animal Ethics Committee Use/CEUA (Number 28/2012) of the UFRN. Macroscopic analysis and cheek pouch samples were removed for histopathologic analysis. Myeloperoxidase (MPO), Malonyldialdehyde (MDA), interleukin-1 beta (IL-1 beta), interleukin-10 (IL-10), and tumour necrosis factor-alpha (TNF-alpha) were analysed by Enzyme Linked Immuno Sorbent Assay (ELISA). Vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), keratinocyte growth factor (KGF), and transforming growth factor (TGF)-alpha were measured by immunohistochemistry. Analysis of variance followed by Bonferroni's test was used to calculate the means of intergroup differences (p <= 0.05). Treatment with 1 mg/kg AZT reduced levels MPO (p<0.01), MDA (p<0.5) and histological inflammatory cell infiltration, and increased the presence of granulation tissue. AZT treatment at 1 mg/kg reduced the TNF-alpha (p<0.05) and IL-1 beta (p<0.05) levels, increased the cheek pouch levels of IL-10 (p<0.01), and upregulated VEGF, FGF, KGF, and TGF-alpha. Administration of AZT at higher doses (5 and 10 mg/kg) did not significantly reverse the OM. AZT at a dose of 1 mg/kg prevented the mucosal damage and inflammation associated with 5-FU-induced OM, increasing granulation and tissue repair.
引用
收藏
页数:16
相关论文
共 42 条
  • [1] Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model
    Araujo, Aurigena A.
    Souza, Tatiana O.
    Moura, Ligia M.
    Brito, Gerly A. C.
    Aragao, Karoline S.
    Araujo, Lorena S.
    Medeiros, Caroline A. X.
    Alves, Maria S. C. F.
    Araujo, Raimundo F., Jr.
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2013, 40 (12) : 1104 - 1111
  • [2] Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis
    Araujo, Aurigena Antunes
    de Souza, Graziene Lopes
    Souza, Tatiana Oliveira
    de Castro Brito, Gerly Anne
    Aragao, Karoline Saboia
    Xavier de Medeiros, Caroline Addison
    Lourenco, Yriu
    Costa Feitosa Alves, Maria do Socorro
    de Araujo, Raimundo Fernandes, Jr.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 (10) : 875 - 884
  • [3] Growth factors and cytokines in wound healing
    Barrientos, Stephan
    Stojadinovic, Olivera
    Golinko, Michael S.
    Brem, Harold
    Tomic-Canic, Marjana
    [J]. WOUND REPAIR AND REGENERATION, 2008, 16 (05) : 585 - 601
  • [4] Wound Macrophages as Key Regulators of Repair Origin, Phenotype, and Function
    Brancato, Samielle K.
    Albina, Jorge E.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (01) : 19 - 25
  • [5] Effect of laser phototherapy in the prevention and treatment of chemo-induced mucositis in hamsters
    Camilo Lopez, Talita Christine
    Martins, Manoela Domingues
    Santos Pavesi, Vanessa Christina
    Ferreira, Leila Soares
    Bussadori, Sandra Kalil
    Moreira, Maria Stella
    Marques, Marcia Martins
    [J]. BRAZILIAN ORAL RESEARCH, 2013, 27 (04): : 342 - 348
  • [6] Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation
    Clancy, Paula
    Koblar, Simon A.
    Golledge, Jonathan
    [J]. ATHEROSCLEROSIS, 2014, 236 (01) : 108 - 115
  • [7] Azilsartan Increases Levels of IL-10, Down-Regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and Up-Regulates OPG in an Experimental Periodontitis Model
    de Araujo, Aurigena Antunes
    Varela, Hugo
    de Castro Brito, Gerly Anne
    Carvalho Xavier de Medeiros, Caroline Addison
    Araujo, Lorena De Souza
    Oliveira do Nascimento, Jose Heriberto
    De Araujo Junior, Raimundo Fernandes
    [J]. PLOS ONE, 2014, 9 (05):
  • [8] de Castro JF, 2013, PHOTOMED LASER SURG
  • [9] DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97
  • [10] Antimicrobial therapy to prevent or treat oral mucositis
    Donnelly, JP
    Bellm, LA
    Epstein, JB
    Sonis, ST
    Symonds, RP
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (07) : 405 - 412